Pharmaceutical manufacturers of Tylosin tartrate

Established in 1876 by Colonel Eli Lilly, Lilly has been dedicated to producing high-quality medications that address genuine needs in a time when unreliable potions were sold by dubious individuals. His encouragement to future generations of staff has been to continuously improve upon what they find. Over 140 years later, we remain steadfast in upholding his vision across all aspects of our operations and the individuals we cater to, beginning with those who use our medications and extending to healthcare professionals, employees, and the communities where we are situated.

Rochem International, Inc. has been a prominent distributor of pharmaceutical, food, nutritional, and animal health ingredients since its establishment in 1994. It procures top-notch ingredients produced in China. With its headquarters in Hauppauge, New York, Rochem operates 16 global offices to meet its clients' requirements. The company's activities adhere to cGMP standards and have undergone audits by the USFDA and various multinational entities. Furthermore, it provides training and conducts audits for its partners to ensure FDA compliance for their technologies and systems.

Apeloa Pharmaceutical Co., Ltd. is a major high-tech enterprise at the state level and a significant player in the pharmaceutical industry in Zhejiang Province. Our company focuses on the exploration, production, and marketing of pharmaceutical goods, primarily specializing in crude drug (API), contract R & D, production service (CDMO), and preparation (FDF) operations. Our product range is predominantly focused on cardio-cerebrovascular, anti-infection, anti-tumor, and other medical treatment areas. Currently, we produce over 70 types of raw materials on a large scale, with 11 of them exceeding 100 million in sales.

We are the primary manufacturer of Avermectin worldwide and the leading producer of Ivermectin in Asia, with an annual production that constitutes half of the total in China. Additionally, we hold the top position as the producer for Tiamulin, Eprinomectin, and Emamectin Benzoate in China.

Established in 1966, Shandong Lukang Pharmaceutical Co., Ltd. (Abbr. Lukang Pharma) is now one of the leading vertically integrated pharmaceutical enterprises in China, engaged in developing, manufacturing, and commercializing API and Finished Dosage Form of Human Drugs, Animal Health, Bio-pesticides, and also general undertaking of CMO business.

Biovet JSC Business Profile. BIOVET stands as a prominent European producer and promoter of medicated and dietary feed supplements, enzymes, large active components, and medications for animal well-being and efficiency.

Ningxia Taiyicin Biotech Co., Ltd.(Previously known as Ningxia pacific Biotech Co.,Ltd.) was founded in June 2010 with a registered capital of RMB 6,250,000,00.00. It is situated in No.1 pacific road, Nuanquan technical area, Helan county, Ningxia province. This company is a wholly owned subsidiary of Ningxia Tairui pharmaceutical CO. Ltd. Initially Taiyicin focused on manufacturing API Erythromycin Thiocyanate. Subsequently, it diversified into the production of several new antibiotics through fermentation, such as lincomycin hydrochloride, and downstream products like Azithromycin, as well as chemical synthesis products in the pharmaceutical field.

Ningxia Tairui Pharmaceutical Co Ltd, also known as Tairui Pharma, is a nationally recognized high-tech enterprise focused on exports. It holds a top AAA credit rating, operates a State-level Enterprise Technical Center and Engineering Laboratory, and boasts a workforce of nearly 3,500 employees